A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery

European Journal of Surgical Oncology

Volumn 29, Issue 3, 2003, Pages 261-265

  Mohamed, F ^a   Marchettini, P ^a   Stuart, O A ^a   Yoo, D ^a   Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Intraperitoneal chemotherapy; Paclitaxel; Peritoneal neoplasms; Pharmacokinetics

Indexed keywords

DRUG CARRIER; GLUCOSE; HETASTARCH; ISOTONIC SOLUTION; PACLITAXEL; PERITONEAL DIALYSIS FLUID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG SOLUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MOLECULAR WEIGHT; PERITONEAL CAVITY; PERITONEUM CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZATION; SURGICAL TECHNIQUE; TUMOR CELL; VENOUS BLOOD;

EID: 0037382610     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1397     Document Type: Article

References (18)

1. Dedrick RL. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol 1985; 12(Suppl 4): 1-6.
2. Elias D, Blot F, El Otmany A et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71-6.
3. Montsarrat B, Marile E, Crois S. Taxol metabolism. Isolation and identification of three major metabolites in rat bile. Drug Med Disp 1990; 18: 895-901.
4. Montsarrat B, Wright M, Dubois J. Taxol metabolism in rat and human bile. Proceedings of Seventh NCI-EORTC Symposium on new Drug Development, March 1992, Amsterdam, p. 123.
5. Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991; 18: 248-54.
6. Kraft AR, Tompkins RK, Jesseph JE. Peritoneal electrolyte absorption: Analysis of portal, systemic venous and lymphatic transport. Surgery 1968; 64: 148-53.
7. Speyer JL, Collins JM, Dedrick RL. Phase I pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 1982; 42: 4265-9.
8. Rowinsky EK, Donehower RC, Jones RJ. Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res 1988; 48: 4093-100.
9. Torres LJ, Litterst CL, Guarino AM. Transport of model compounds across the peritoneal membrane in the rat. Pharmacology 1978; 17: 330-40.
10. Kuh HJ, Jang SH, Wientjes MG, Weaver JR, Au JL. Determinants of paclitaxel penetration and accumulation in human solid tumour. J Pharmacol Exper Therapeut 1999; 290(2): 871-80.
11. Pestieau SR, Schnake KJ, Stuart OA, Sugarbaker PH. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Cancer Chemot Pharmacol 2001; 47: 269-76.
12. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221: 29-42.
13. Lee SH, Yoo SD, Lee KH. Rapid and sensitive determination of paclitaxel concentration in mouse plasma by high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999; 724(2): 357.
14. Alberts DS, Liu PY, Harrigan EV et al. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. NEJM 1996; 335(26): 1950.
15. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998; 228(3): 347.
16. Rosenhei N, Blake D, McIntyre PA et al. The effect of volume on the distribution of substances instilled in the peritoneal cavity. Gynecol Oncol 1978; 6: 106.
17. Rubin J, Jones Q, Planch A, Bower J, Klein E. Substitution of a starch polymer for glucose in peritoneal dialysis. Nephron 1985; 39(1): 40.
18. Brenner DE. Intraperitoneal chemotherapy: a review. J Clin Oncol 1986; 4(7): 1135.